Request for Covid-19 Impact Assessment of this Report
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume) , revenue (value) , market share and growth rate of Cord Blood Stem Cells in these regions, from 2012 to 2022 (forecast) .
United States Cord Blood Stem Cells market competition by top manufacturers/players, with Cord Blood Stem Cells sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
3Dmatrix
Aldagen
Angioblast Systems
Athersys
Beike Biotechnology
Biotime
Brainstorm Cell Therapeutics
Caladrius Biosciences
Capricor
Cellerant Therapeutics
Gamida Cell
Globalstem
Hybrid Organ
Intellicell Biosciences
International Stem Cell
Juventas Therapeutics
Mesoblast
Neuralstem
Neurogeneration
Ocata
Osiris Therapeutics
Primegen Biotech
Reneuron Group
Rhinocyte
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Allogeneic Stem Cell
Autologous Stem Cell
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Cord Blood Stem Cells for each application, including
Autoimmune Diseases
Immunodeficiencies
Malignancies,Caners
Solid Tumors
Others
United States Cord Blood Stem Cells Market Report 2017
1 Cord Blood Stem Cells Overview
1.1 Product Overview and Scope of Cord Blood Stem Cells
1.2 Classification of Cord Blood Stem Cells by Product Category
1.2.1 United States Cord Blood Stem Cells Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Cord Blood Stem Cells Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Allogeneic Stem Cell
1.2.4 Autologous Stem Cell
1.3 United States Cord Blood Stem Cells Market by Application/End Users
1.3.1 United States Cord Blood Stem Cells Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Autoimmune Diseases
1.3.3 Immunodeficiencies
1.3.4 Malignancies,Caners
1.3.5 Solid Tumors
1.3.6 Others
1.4 United States Cord Blood Stem Cells Market by Region
1.4.1 United States Cord Blood Stem Cells Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Cord Blood Stem Cells Status and Prospect (2012-2022)
1.4.3 Southwest Cord Blood Stem Cells Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Cord Blood Stem Cells Status and Prospect (2012-2022)
1.4.5 New England Cord Blood Stem Cells Status and Prospect (2012-2022)
1.4.6 The South Cord Blood Stem Cells Status and Prospect (2012-2022)
1.4.7 The Midwest Cord Blood Stem Cells Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Cord Blood Stem Cells (2012-2022)
1.5.1 United States Cord Blood Stem Cells Sales and Growth Rate (2012-2022)
1.5.2 United States Cord Blood Stem Cells Revenue and Growth Rate (2012-2022)
2 United States Cord Blood Stem Cells Market Competition by Players/Suppliers
2.1 United States Cord Blood Stem Cells Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Cord Blood Stem Cells Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Cord Blood Stem Cells Average Price by Players/Suppliers (2012-2017)
2.4 United States Cord Blood Stem Cells Market Competitive Situation and Trends
2.4.1 United States Cord Blood Stem Cells Market Concentration Rate
2.4.2 United States Cord Blood Stem Cells Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Cord Blood Stem Cells Manufacturing Base Distribution, Sales Area, Product Type
3 United States Cord Blood Stem Cells Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Cord Blood Stem Cells Sales and Market Share by Region (2012-2017)
3.2 United States Cord Blood Stem Cells Revenue and Market Share by Region (2012-2017)
3.3 United States Cord Blood Stem Cells Price by Region (2012-2017)
4 United States Cord Blood Stem Cells Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Cord Blood Stem Cells Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Cord Blood Stem Cells Revenue and Market Share by Type (2012-2017)
4.3 United States Cord Blood Stem Cells Price by Type (2012-2017)
4.4 United States Cord Blood Stem Cells Sales Growth Rate by Type (2012-2017)
5 United States Cord Blood Stem Cells Sales (Volume) by Application (2012-2017)
5.1 United States Cord Blood Stem Cells Sales and Market Share by Application (2012-2017)
5.2 United States Cord Blood Stem Cells Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Cord Blood Stem Cells Players/Suppliers Profiles and Sales Data
6.1 3Dmatrix
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Cord Blood Stem Cells Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 3Dmatrix Cord Blood Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Aldagen
6.2.2 Cord Blood Stem Cells Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Aldagen Cord Blood Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Angioblast Systems
6.3.2 Cord Blood Stem Cells Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Angioblast Systems Cord Blood Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Athersys
6.4.2 Cord Blood Stem Cells Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Athersys Cord Blood Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Beike Biotechnology
6.5.2 Cord Blood Stem Cells Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Beike Biotechnology Cord Blood Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Biotime
6.6.2 Cord Blood Stem Cells Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Biotime Cord Blood Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Brainstorm Cell Therapeutics
6.7.2 Cord Blood Stem Cells Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Brainstorm Cell Therapeutics Cord Blood Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Caladrius Biosciences
6.8.2 Cord Blood Stem Cells Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Caladrius Biosciences Cord Blood Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Capricor
6.9.2 Cord Blood Stem Cells Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Capricor Cord Blood Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Cellerant Therapeutics
6.10.2 Cord Blood Stem Cells Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Cellerant Therapeutics Cord Blood Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Gamida Cell
6.12 Globalstem
6.13 Hybrid Organ
6.14 Intellicell Biosciences
6.15 International Stem Cell
6.16 Juventas Therapeutics
6.17 Mesoblast
6.18 Neuralstem
6.19 Neurogeneration
6.20 Ocata
6.21 Osiris Therapeutics
6.22 Primegen Biotech
6.23 Reneuron Group
6.24 Rhinocyte
7 Cord Blood Stem Cells Manufacturing Cost Analysis
7.1 Cord Blood Stem Cells Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cord Blood Stem Cells
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Cord Blood Stem Cells Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cord Blood Stem Cells Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Cord Blood Stem Cells Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Cord Blood Stem Cells Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Cord Blood Stem Cells Sales Volume Forecast by Type (2017-2022)
11.3 United States Cord Blood Stem Cells Sales Volume Forecast by Application (2017-2022)
11.4 United States Cord Blood Stem Cells Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
Figure Product Picture of Cord Blood Stem Cells
Figure United States Cord Blood Stem Cells Market Size (K Units) by Type (2012-2022)
Figure United States Cord Blood Stem Cells Sales Volume Market Share by Type (Product Category) in 2016
Figure Allogeneic Stem Cell Product Picture
Figure Autologous Stem Cell Product Picture
Figure United States Cord Blood Stem Cells Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Cord Blood Stem Cells by Application in 2016
Figure Autoimmune Diseases Examples
Figure Immunodeficiencies Examples
Figure Malignancies,Caners Examples
Figure Solid Tumors Examples
Figure Others Examples
Figure United States Cord Blood Stem Cells Market Size (Million USD) by Region (2012-2022)
Figure The West Cord Blood Stem Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Cord Blood Stem Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Cord Blood Stem Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Cord Blood Stem Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Cord Blood Stem Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Cord Blood Stem Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cord Blood Stem Cells Sales (K Units) and Growth Rate (2012-2022)
Figure United States Cord Blood Stem Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cord Blood Stem Cells Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Cord Blood Stem Cells Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Cord Blood Stem Cells Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cord Blood Stem Cells Sales Share by Players/Suppliers
Figure 2017 United States Cord Blood Stem Cells Sales Share by Players/Suppliers
Figure United States Cord Blood Stem Cells Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Cord Blood Stem Cells Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Cord Blood Stem Cells Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cord Blood Stem Cells Revenue Share by Players/Suppliers
Figure 2017 United States Cord Blood Stem Cells Revenue Share by Players/Suppliers
Table United States Market Cord Blood Stem Cells Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Cord Blood Stem Cells Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Cord Blood Stem Cells Market Share of Top 3 Players/Suppliers
Figure United States Cord Blood Stem Cells Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Cord Blood Stem Cells Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Cord Blood Stem Cells Product Category
Table United States Cord Blood Stem Cells Sales (K Units) by Region (2012-2017)
Table United States Cord Blood Stem Cells Sales Share by Region (2012-2017)
Figure United States Cord Blood Stem Cells Sales Share by Region (2012-2017)
Figure United States Cord Blood Stem Cells Sales Market Share by Region in 2016
Table United States Cord Blood Stem Cells Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Cord Blood Stem Cells Revenue Share by Region (2012-2017)
Figure United States Cord Blood Stem Cells Revenue Market Share by Region (2012-2017)
Figure United States Cord Blood Stem Cells Revenue Market Share by Region in 2016
Table United States Cord Blood Stem Cells Price (USD/Unit) by Region (2012-2017)
Table United States Cord Blood Stem Cells Sales (K Units) by Type (2012-2017)
Table United States Cord Blood Stem Cells Sales Share by Type (2012-2017)
Figure United States Cord Blood Stem Cells Sales Share by Type (2012-2017)
Figure United States Cord Blood Stem Cells Sales Market Share by Type in 2016
Table United States Cord Blood Stem Cells Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Cord Blood Stem Cells Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cord Blood Stem Cells by Type (2012-2017)
Figure Revenue Market Share of Cord Blood Stem Cells by Type in 2016
Table United States Cord Blood Stem Cells Price (USD/Unit) by Types (2012-2017)
Figure United States Cord Blood Stem Cells Sales Growth Rate by Type (2012-2017)
Table United States Cord Blood Stem Cells Sales (K Units) by Application (2012-2017)
Table United States Cord Blood Stem Cells Sales Market Share by Application (2012-2017)
Figure United States Cord Blood Stem Cells Sales Market Share by Application (2012-2017)
Figure United States Cord Blood Stem Cells Sales Market Share by Application in 2016
Table United States Cord Blood Stem Cells Sales Growth Rate by Application (2012-2017)
Figure United States Cord Blood Stem Cells Sales Growth Rate by Application (2012-2017)
Table 3Dmatrix Basic Information List
Table 3Dmatrix Cord Blood Stem Cells Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)
Figure 3Dmatrix Cord Blood Stem Cells Sales Growth Rate (2012-2017)
Figure 3Dmatrix Cord Blood Stem Cells Sales Market Share in United States (2012-2017)
Figure 3Dmatrix Cord Blood Stem Cells Revenue Market Share in United States (2012-2017)
Table Aldagen Basic Information List
Table Aldagen Cord Blood Stem Cells Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aldagen Cord Blood Stem Cells Sales Growth Rate (2012-2017)
Figure Aldagen Cord Blood Stem Cells Sales Market Share in United States (2012-2017)
Figure Aldagen Cord Blood Stem Cells Revenue Market Share in United States (2012-2017)
Table Angioblast Systems Basic Information List
Table Angioblast Systems Cord Blood Stem Cells Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)
Figure Angioblast Systems Cord Blood Stem Cells Sales Growth Rate (2012-2017)
Figure Angioblast Systems Cord Blood Stem Cells Sales Market Share in United States (2012-2017)
Figure Angioblast Systems Cord Blood Stem Cells Revenue Market Share in United States (2012-2017)
Table Athersys Basic Information List
Table Athersys Cord Blood Stem Cells Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)
Figure Athersys Cord Blood Stem Cells Sales Growth Rate (2012-2017)
Figure Athersys Cord Blood Stem Cells Sales Market Share in United States (2012-2017)
Figure Athersys Cord Blood Stem Cells Revenue Market Share in United States (2012-2017)
Table Beike Biotechnology Basic Information List
Table Beike Biotechnology Cord Blood Stem Cells Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)
Figure Beike Biotechnology Cord Blood Stem Cells Sales Growth Rate (2012-2017)
Figure Beike Biotechnology Cord Blood Stem Cells Sales Market Share in United States (2012-2017)
Figure Beike Biotechnology Cord Blood Stem Cells Revenue Market Share in United States (2012-2017)
Table Biotime Basic Information List
Table Biotime Cord Blood Stem Cells Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biotime Cord Blood Stem Cells Sales Growth Rate (2012-2017)
Figure Biotime Cord Blood Stem Cells Sales Market Share in United States (2012-2017)
Figure Biotime Cord Blood Stem Cells Revenue Market Share in United States (2012-2017)
Table Brainstorm Cell Therapeutics Basic Information List
Table Brainstorm Cell Therapeutics Cord Blood Stem Cells Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)
Figure Brainstorm Cell Therapeutics Cord Blood Stem Cells Sales Growth Rate (2012-2017)
Figure Brainstorm Cell Therapeutics Cord Blood Stem Cells Sales Market Share in United States (2012-2017)
Figure Brainstorm Cell Therapeutics Cord Blood Stem Cells Revenue Market Share in United States (2012-2017)
Table Caladrius Biosciences Basic Information List
Table Caladrius Biosciences Cord Blood Stem Cells Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)
Figure Caladrius Biosciences Cord Blood Stem Cells Sales Growth Rate (2012-2017)
Figure Caladrius Biosciences Cord Blood Stem Cells Sales Market Share in United States (2012-2017)
Figure Caladrius Biosciences Cord Blood Stem Cells Revenue Market Share in United States (2012-2017)
Table Capricor Basic Information List
Table Capricor Cord Blood Stem Cells Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)
Figure Capricor Cord Blood Stem Cells Sales Growth Rate (2012-2017)
Figure Capricor Cord Blood Stem Cells Sales Market Share in United States (2012-2017)
Figure Capricor Cord Blood Stem Cells Revenue Market Share in United States (2012-2017)
Table Cellerant Therapeutics Basic Information List
Table Cellerant Therapeutics Cord Blood Stem Cells Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cellerant Therapeutics Cord Blood Stem Cells Sales Growth Rate (2012-2017)
Figure Cellerant Therapeutics Cord Blood Stem Cells Sales Market Share in United States (2012-2017)
Figure Cellerant Therapeutics Cord Blood Stem Cells Revenue Market Share in United States (2012-2017)
Table Gamida Cell Basic Information List
Table Globalstem Basic Information List
Table Hybrid Organ Basic Information List
Table Intellicell Biosciences Basic Information List
Table International Stem Cell Basic Information List
Table Juventas Therapeutics Basic Information List
Table Mesoblast Basic Information List
Table Neuralstem Basic Information List
Table Neurogeneration Basic Information List
Table Ocata Basic Information List
Table Osiris Therapeutics Basic Information List
Table Primegen Biotech Basic Information List
Table Reneuron Group Basic Information List
Table Rhinocyte Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cord Blood Stem Cells
Figure Manufacturing Process Analysis of Cord Blood Stem Cells
Figure Cord Blood Stem Cells Industrial Chain Analysis
Table Raw Materials Sources of Cord Blood Stem Cells Major Players/Suppliers in 2016
Table Major Buyers of Cord Blood Stem Cells
Table Distributors/Traders List
Figure United States Cord Blood Stem Cells Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Cord Blood Stem Cells Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Cord Blood Stem Cells Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Cord Blood Stem Cells Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Cord Blood Stem Cells Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Cord Blood Stem Cells Sales Volume (K Units) Forecast by Type in 2022
Table United States Cord Blood Stem Cells Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Cord Blood Stem Cells Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Cord Blood Stem Cells Sales Volume (K Units) Forecast by Application in 2022
Table United States Cord Blood Stem Cells Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Cord Blood Stem Cells Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cord Blood Stem Cells Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cord Blood Stem Cells Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...